Booth 3070
Cambridge, United Kingdom
VECTURA LIMITED is a specialist CDMO providing consultative, flexible and innovative inhaled preclinical toxicology, drug-device combination development and clinical trial manufacturing services to help companies bring their medicines to patients.

With more than 12 years of preclinical toxicology expertise, we provide a comprehensive and consultative range of end-to-end contract services, including in vivo toxicology (routes of administration: Inhalation, oral, s.c., i.v., i.m., i.p. & i.t), in vitro toxicology and, bioanalytical and analytical services. Our studies are performed in accordance with the OECD guidelines and are recognized internationally for regulatory submissions in all OECD adherent countries including key markets: US, EU and APAC.

In addition to our preclinical services, we offer formulation development in combination with our award-winning Blister Dry Powder Inhalers and highly efficient, breath-actuated, dose-sparing Mesh Nebuliser to our clients. Alternatively, we can work with your device or off-the-shelf technologies. Vectura has been successfully developing complex inhaled products for over 25 years and we are ready to help you progress your inhaled programme.

For a list of services we offer, please visit our booth #3070 at BIO. Schedule a meeting with us to help you with your drug development goals.